Therapeutic agents in the medical management of sinusitis.
Surgical approaches to the management of sinus disease have undergone a significant change over the past decade. The rhinologist must appreciate that the medical management of sinusitis also has been radically altered during the past 10 years by the development of newer and better pharmacotherapeutic agents for the treatment of sinusitis. These agents are best employed as part of an ordered approach to treatment with a full knowledge of their proper applications and potential drawbacks.
Mabry
R L
RL
University of Texas Southwestern Medical Center, Dallas.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008297:Male; D014663:Nasal Decongestants / Q000627:therapeutic use*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery / Q000628:therapy
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005100:Expectorants; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants